Hims & Hers to Advertise Weight-Loss Shots at Super Bowl

‘Incredibly irresponsible’: Hims Super Bowl ad downplays risks of compounded drugs
A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded weight loss drugs.
Hims & Hers to Advertise Weight-Loss Shots at the Super Bowl
Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced injectables.
Thinner Amid Gluttony? Hims & Hers Debuts First SB Ads For Weight-Loss Drugs
Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable."
Hims & Hers Hopes Super Bowl Commercial About Obesity Stands Apart From Pack of Snacks
Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot that discusses obesity
Hims & Hers to air its first Super Bowl spot, promoting weight loss drugs
The Super Bowl spot is part of a larger campaign as Hims & Hers continues to highlight its weight loss treatments. The ad will air after Feb. 9 in 30-, 15- and 6-second versions on both broadcast and digital channels. The brand worked with Tinuiti on media duties.
Hims & Hers set for Super Bowl ad debut highlighting GLP-1 weight loss drugs
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the heart of the ongoing GLP-1 phenomenon.
Is Hims & Hers Health Stock a Buy?
Hims & Hers Health (NYSE: HIMS) is a relatively young company addressing age-old healthcare challenges by offering ...
bovnews4h
Hims & Hers Health Inc (HIMS) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.51 which represents a decrease of $-0.36 or -1.17% from the prior close of $30.87. The stock opened at $29.28 and touched a low ...
A Closer Look at Hims & Hers Health's Options Market Dynamics
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...
Campaign US6h
Hims & Hers has a new definition for ‘This is America’
Hims & Hers and similar companies allow consumers to make virtual appointments with healthcare providers and obtain ...
Hims & Hers: Ready To Outperform Further
Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...
Is Hims & Hers Stock in Trouble?
Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...
Hims & Hers CEO Andrew Dudum sells $815k in stock
Andrew Dudum, the CEO of Hims & Hers Health Inc. (NYSE:HIMS), recently sold shares worth approximately $815,029, according to ...
news.stocktradersdaily2d
(HIMS) Investment Analysis and Advice
Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.